O'Brien Stephanie Monaghan

CIK 00017209071 companyWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001720907

Recent Transactions

30 trades

Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−5,748→ 0 total
Disposition from Tender
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−5,750→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−3,062→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−5,744→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−7,961→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−3,877→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−3,544→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−17,580→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−121,894→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−14,684→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−27,600→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−11,199→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−8,554→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−7,441→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−27,600→ 0 total
Disposition from Tender
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−25,666→ 0 total
Other
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-04-06+5,750→ 5,750 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-01-01+7,961→ 25,666 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2026-01-01+14,684→ 14,684 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2025-01-01+11,199→ 11,199 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-01-01+6,267→ 17,705 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2024-01-01$59.86/sh+5,748→ 5,748 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-01-01+3,341→ 11,438 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-01-01+3,867→ 8,097 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2023-01-01+7,441→ 7,441 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2022-01-01+8,554→ 8,554 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-01-01+4,230→ 4,230 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2021-01-01+27,600→ 27,600 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2020-01-01$30.62/sh+27,600→ 27,600 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock option (right to buy)
2019-01-01+17,580→ 17,580 total

Companies

Apellis Pharmaceuticals, Inc.
Director
$APLS

Recent Filings

Address

C/O APELLIS PHARMACEUTICALS, INC. 100 FIFTH AVENUE, 3RD FLOOR

WALTHAM, MA, 02451

View on SEC.gov